In this retrospective cohort study of electronic health records (EHRs) from the TriNetX Analytics Network, a global federated health research network of approximately 105.3 million patients from 61 large healthcare organizations in the US, we aimed to assess the associations of semaglutide with both incident and recurrent CUD diagnosis compared to non-GLP-1RA anti-obesity or anti-diabetes medications
I asked about Tirzepatide vs Semaglutide in Jupiter
No evidence of increase in calcitonin concentrations or development of C-cell malignancy in response to liraglutide for up to 5 years in the LEADER Trial
Remedy Meds Positive: Consistently praised for transparent pricing, good communication, and supportive clinicians
They should also be avoided in patients with inflammatory bowel diseases ulcerative colitis is a good example
Factors that may contribute to non-response include extremely chronic structural degeneration, product quality issues, improper storage or reconstitution, or individual variations in peptide metabolism